Lung Cancer Medicare Access to Precise Testing Act
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
This bill amends the Medicare program to require coverage of lung cancer biomarker testing for Medicare beneficiaries diagnosed with lung cancer, effective January 1, 2027. Biomarker testing involves analyzing a patient's tissue, blood, or bodily fluids to identify specific genetic, protein, or molecular markers. Medicare would cover 100 percent of reasonable charges for such testing.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.